<p><strong>表格 8.5 (EPT/RI)</strong></p>
<p><strong>豁免主要交易者与认可中介身份的公开交易披露，服务于客户的能力</strong></p>
<p><strong>收购守则第 8.5 条（“守则”）</strong></p>
<p><strong>1. 关键信息</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>(a) 豁免主要交易者名称：</strong></td>
<td>Investec Bank plc</td>
</tr>
<tr>
<td><strong>(b) 本表格所涉及的要约方/被要约方的相关证券名称：</strong> <em>每个要约方/被要约方使用单独的表格</em></td>
<td>Advanced Medical Solutions Group Plc</td>
</tr>
<tr>
<td><strong>(c) 与豁免主要交易者相关的要约方名称：</strong></td>
<td>Investec 是 Advanced Medical Solutions Group plc 的顾问和联合经纪人</td>
</tr>
<tr>
<td><strong>(d) 交易日期：</strong></td>
<td>2026 年 4 月 30 日</td>
</tr>
<tr>
<td><strong>(e) 除上述 1(b) 中的公司外，豁免主要交易者是否在披露任何其他要约方的相关信息？</strong> <em>如果是现金要约或可能的现金要约，请注明 “无”</em></td>
<td><em>无</em></td>
</tr>
</tbody>
</table>
<p><strong>2. 豁免主要交易者的交易</strong></p>
<p><em>如果在 1(b) 中提到的要约方或被要约方的相关证券中有多个类别的交易，请为每个额外的相关证券类别复制表格 2(a)、(b)、(c) 或 (d)（视情况而定）。</em></p>
<p><em>所有价格和其他货币金额的货币单位应予以说明。</em></p>
<p><strong>(a) 购买和销售</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>普通股</td>
</tr>
<tr>
<td><strong>购买/销售</strong></td>
<td>销售</td>
</tr>
<tr>
<td><strong>证券总数</strong></td>
<td>13,080</td>
</tr>
<tr>
<td><strong>每单位支付/收到的最高价格</strong></td>
<td>245.5</td>
</tr>
<tr>
<td><strong>每单位支付/收到的最低价格</strong></td>
<td>245.5</td>
</tr>
</tbody>
</table>
<p><strong>(b) 现金结算衍生交易</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>产品描述</strong> <em>例如 CFD</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>交易性质</strong> <em>例如 开立/平仓多头/空头头寸，增加/减少多头/空头头寸</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>参考证券数量</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位价格</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
<p><strong>(c) 股票结算衍生交易（包括期权）</strong></p>
<p><strong>(i) 写入、出售、购买或变更</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>产品描述</strong> <em>例如 看涨期权</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>写入、购买、出售、变更等</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>与期权相关的证券数量</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位行使价格</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>类型</strong> <em>例如 美式、欧式等</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>到期日</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位支付/收到的期权金</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
<p><strong>(ii) 行使</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>产品描述</strong> <em>例如 看涨期权</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>行使/被行使</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>证券数量</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位行使价格</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
<p><strong>(d) 其他交易（包括认购新证券）</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>交易性质</strong> <em>例如 认购、转换</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>详情</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位价格（如适用）</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
<p><strong>3. 其他信息</strong></p>
<p><strong>(a) 赔偿和其他交易安排</strong></p>
<ul>
<li><strong>有关豁免主要交易者与任何要约方或与要约方协同行动的任何人的相关证券的赔偿或期权安排，或任何协议或理解（正式或非正式）的详情，这可能是促使交易或避免交易的诱因：</strong> <em>不可撤销的承诺和意向书不应包括。如果没有此类协议、安排或理解，请注明 “无”</em></li>
<li>无</li>
</ul>
<p><strong>(b) 与期权或衍生品相关的协议、安排或理解</strong></p>
<ul>
<li><strong>有关豁免主要交易者与任何其他人之间的任何协议、安排或理解（正式或非正式）的详情，涉及：</strong> <strong>(i) 任何相关证券在任何期权下的投票权；或</strong> <strong>(ii) 任何衍生品所参考的相关证券的投票权或未来的收购或处置：</strong> <em>如果没有此类协议、安排或理解，请注明 “无”</em></li>
<li>无</li>
</ul>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>披露日期：</strong></td>
<td><strong>2026 年 5 月 1 日</strong></td>
</tr>
<tr>
<td><strong>联系人姓名：</strong></td>
<td><strong>Priyali Bhattacharjee</strong></td>
</tr>
<tr>
<td><strong>联系电话：</strong></td>
<td><strong>+91-9923757332</strong></td>
</tr>
</tbody>
</table>
<p><em>根据守则第 8 条的公开披露必须向监管信息服务进行。</em></p>
<p><em>面板的市场监测单位可就守则的交易披露要求进行咨询，电话 +44 (0) 20 7638 0129。</em></p>
<p><em>守则可在面板网站上查看，网址为 sssssssw</em> <em>www.thetakeoverpanel.org.uk</em> <em>.</em></p>

<p>Investec Bank plc（作为豁免主要交易商）关于在 Advanced Medical Solutions Group plc 的交易的 Form 8.5（EPT/RI）披露。2026 年 4 月 30 日，Investec 以每单位 245.5 的价格出售了 13,080 股普通股。没有报告其他交易或协议。该披露由 Priyali Bhattacharjee 于 2026 年 5 月 1 日发布，并提供了进一步咨询收购守则的联系方式</p>

<p><strong>FORM 8.5 (EPT/RI)</strong></p>
<div class="lb-trans"><p><strong>表格 8.5 (EPT/RI)</strong></p>
</div><p><strong>PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY</strong></p>
<div class="lb-trans"><p><strong>豁免主要交易者与认可中介身份的公开交易披露，服务于客户的能力</strong></p>
</div><p><strong>Rule 8.5 of the Takeover Code (the “Code”)</strong></p>
<div class="lb-trans"><p><strong>收购守则第 8.5 条（“守则”）</strong></p>
</div><p><strong>1. KEY INFORMATION</strong></p>
<div class="lb-trans"><p><strong>1. 关键信息</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>(a) Name of exempt principal trader:</strong></td>
<td>Investec Bank plc</td>
</tr>
<tr>
<td><strong>(b) Name of offeror/offeree in relation to whose relevant securities this form relates:</strong> <em>Use a separate form for each offeror/offeree</em></td>
<td>Advanced Medical Solutions Group Plc</td>
</tr>
<tr>
<td><strong>(c) Name of the party to the offer with which exempt principal trader is connected:</strong></td>
<td>Investec is Advisor &amp; Joint Broker to Advanced Medical Solutions Group plc</td>
</tr>
<tr>
<td><strong>(d) Date dealing undertaken:</strong></td>
<td>30th April 2026</td>
</tr>
<tr>
<td><strong>(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?</strong> <em>If it is a cash offer or possible cash offer, state “N/A”</em></td>
<td><em>N/A</em></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>(a) 豁免主要交易者名称：</strong></td>
<td>Investec Bank plc</td>
</tr>
<tr>
<td><strong>(b) 本表格所涉及的要约方/被要约方的相关证券名称：</strong> <em>每个要约方/被要约方使用单独的表格</em></td>
<td>Advanced Medical Solutions Group Plc</td>
</tr>
<tr>
<td><strong>(c) 与豁免主要交易者相关的要约方名称：</strong></td>
<td>Investec 是 Advanced Medical Solutions Group plc 的顾问和联合经纪人</td>
</tr>
<tr>
<td><strong>(d) 交易日期：</strong></td>
<td>2026 年 4 月 30 日</td>
</tr>
<tr>
<td><strong>(e) 除上述 1(b) 中的公司外，豁免主要交易者是否在披露任何其他要约方的相关信息？</strong> <em>如果是现金要约或可能的现金要约，请注明 “无”</em></td>
<td><em>无</em></td>
</tr>
</tbody>
</table>
</div><p><strong>2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER</strong></p>
<div class="lb-trans"><p><strong>2. 豁免主要交易者的交易</strong></p>
</div><p><em>Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.</em></p>
<div class="lb-trans"><p><em>如果在 1(b) 中提到的要约方或被要约方的相关证券中有多个类别的交易，请为每个额外的相关证券类别复制表格 2(a)、(b)、(c) 或 (d)（视情况而定）。</em></p>
</div><p><em>The currency of all prices and other monetary amounts should be stated.</em></p>
<div class="lb-trans"><p><em>所有价格和其他货币金额的货币单位应予以说明。</em></p>
</div><p><strong>(a) Purchases and sales</strong></p>
<div class="lb-trans"><p><strong>(a) 购买和销售</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>Ordinary shares</td>
</tr>
<tr>
<td><strong>Purchases/ sales</strong></td>
<td>Sales</td>
</tr>
<tr>
<td><strong>Total number of securities</strong></td>
<td>13,080</td>
</tr>
<tr>
<td><strong>Highest price per unit paid/received</strong></td>
<td>245.5</td>
</tr>
<tr>
<td><strong>Lowest price per unit paid/received</strong></td>
<td>245.5</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>普通股</td>
</tr>
<tr>
<td><strong>购买/销售</strong></td>
<td>销售</td>
</tr>
<tr>
<td><strong>证券总数</strong></td>
<td>13,080</td>
</tr>
<tr>
<td><strong>每单位支付/收到的最高价格</strong></td>
<td>245.5</td>
</tr>
<tr>
<td><strong>每单位支付/收到的最低价格</strong></td>
<td>245.5</td>
</tr>
</tbody>
</table>
</div><p><strong>(b) Cash-settled derivative transactions</strong></p>
<div class="lb-trans"><p><strong>(b) 现金结算衍生交易</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Product description</strong> <em>e.g. CFD</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Nature of dealing</strong> <em>e.g. opening/closing a long/short position, increasing/reducing a long/short position</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Number of reference securities</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Price per unit</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>产品描述</strong> <em>例如 CFD</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>交易性质</strong> <em>例如 开立/平仓多头/空头头寸，增加/减少多头/空头头寸</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>参考证券数量</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位价格</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
</div><p><strong>(c) Stock-settled derivative transactions (including options)</strong></p>
<div class="lb-trans"><p><strong>(c) 股票结算衍生交易（包括期权）</strong></p>
</div><p><strong>(i) Writing, selling, purchasing or varying</strong></p>
<div class="lb-trans"><p><strong>(i) 写入、出售、购买或变更</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Product description</strong> <em>e.g. call option</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Writing, purchasing, selling, varying etc.</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Number of securities to which option relates</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Exercise price per unit</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Type</strong> <em>e.g. American, European etc.</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Expiry date</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Option money paid/ received per unit</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>产品描述</strong> <em>例如 看涨期权</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>写入、购买、出售、变更等</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>与期权相关的证券数量</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位行使价格</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>类型</strong> <em>例如 美式、欧式等</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>到期日</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位支付/收到的期权金</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
</div><p><strong>(ii) Exercise</strong></p>
<div class="lb-trans"><p><strong>(ii) 行使</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Product description</strong> <em>e.g. call option</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Exercising/ exercised against</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Number of securities</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Exercise price per unit</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>产品描述</strong> <em>例如 看涨期权</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>行使/被行使</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>证券数量</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位行使价格</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
</div><p><strong>(d) Other dealings (including subscribing for new securities)</strong></p>
<div class="lb-trans"><p><strong>(d) 其他交易（包括认购新证券）</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Nature of dealing</strong> <em>e.g. subscription, conversion</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Details</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Price per unit (if applicable)</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相关证券类别</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>交易性质</strong> <em>例如 认购、转换</em></td>
<td>无</td>
</tr>
<tr>
<td><strong>详情</strong></td>
<td>无</td>
</tr>
<tr>
<td><strong>每单位价格（如适用）</strong></td>
<td>无</td>
</tr>
</tbody>
</table>
</div><p><strong>3. OTHER INFORMATION</strong></p>
<div class="lb-trans"><p><strong>3. 其他信息</strong></p>
</div><p><strong>(a) Indemnity and other dealing arrangements</strong></p>
<div class="lb-trans"><p><strong>(a) 赔偿和其他交易安排</strong></p>
</div><ul>
<li><strong>Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:</strong> <em>Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”</em></li>
<li>None</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>有关豁免主要交易者与任何要约方或与要约方协同行动的任何人的相关证券的赔偿或期权安排，或任何协议或理解（正式或非正式）的详情，这可能是促使交易或避免交易的诱因：</strong> <em>不可撤销的承诺和意向书不应包括。如果没有此类协议、安排或理解，请注明 “无”</em></li>
<li>无</li>
</ul>
</div><p><strong>(b) Agreements, arrangements or understandings relating to options or derivatives</strong></p>
<div class="lb-trans"><p><strong>(b) 与期权或衍生品相关的协议、安排或理解</strong></p>
</div><ul>
<li><strong>Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:</strong> <strong>(i) the voting rights of any relevant securities under any option; or</strong> <strong>(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:</strong> <em>If there are no such agreements, arrangements or understandings, state “none”</em></li>
<li>None</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>有关豁免主要交易者与任何其他人之间的任何协议、安排或理解（正式或非正式）的详情，涉及：</strong> <strong>(i) 任何相关证券在任何期权下的投票权；或</strong> <strong>(ii) 任何衍生品所参考的相关证券的投票权或未来的收购或处置：</strong> <em>如果没有此类协议、安排或理解，请注明 “无”</em></li>
<li>无</li>
</ul>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Date of disclosure:</strong></td>
<td><strong>01 May 2026</strong></td>
</tr>
<tr>
<td><strong>Contact name:</strong></td>
<td><strong>Priyali Bhattacharjee</strong></td>
</tr>
<tr>
<td><strong>Telephone number:</strong></td>
<td><strong>+91-9923757332</strong></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>披露日期：</strong></td>
<td><strong>2026 年 5 月 1 日</strong></td>
</tr>
<tr>
<td><strong>联系人姓名：</strong></td>
<td><strong>Priyali Bhattacharjee</strong></td>
</tr>
<tr>
<td><strong>联系电话：</strong></td>
<td><strong>+91-9923757332</strong></td>
</tr>
</tbody>
</table>
</div><p><em>Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.</em></p>
<div class="lb-trans"><p><em>根据守则第 8 条的公开披露必须向监管信息服务进行。</em></p>
</div><p><em>The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0) 20 7638 0129.</em></p>
<div class="lb-trans"><p><em>面板的市场监测单位可就守则的交易披露要求进行咨询，电话 +44 (0) 20 7638 0129。</em></p>
</div><p><em>The Code can be viewed on the Panel’s website at sssssssw</em> <em>www.thetakeoverpanel.org.uk</em> <em>.</em></p>
<div class="lb-trans"><p><em>守则可在面板网站上查看，网址为 sssssssw</em> <em>www.thetakeoverpanel.org.uk</em> <em>.</em></p>
</div>

表格 8.5（EPT/RI）- Advanced Medical Solutions Group plc